CAS 934740-33-7

Fórmula: C33H42N4O6

InChI: InChI=1S/C33H42N4O6/c1-2-18-36(32(39)43-23-25-12-14-30(15-13-25)37(41)42)29-16-19-34(20-17-29)21-28-22-35(31(38)26-8-6-7-9-26)24-33(28,40)27-10-4-3-5-11-27/h2-5,10-15,26,28-29,40H,1,6-9,16-24H2/t28-,33-/m0/s1

Chave InChI: JNSKQYZFEVKYDB-UVMMSNCQSA-N

SMILES: C=CCN(C1CCN(CC1)C[C@H]2CN(C[C@@]2(C3=CC=CC=C3)O)C(=O)C4CCCC4)C(=O)OCC5=CC=C(C=C5)[N+](=O)[O-]

Nifeviroc

CAS: 934740-33-7

Fórmula: C₃₃H₄₂N₄O₆

Pureza: 98%

Peso molecular: 590.7098

Ref: IN-DA00IHN2

Nifeviroc

CAS: 934740-33-7

Nifeviroc is a peptide that belongs to the class of activators. It is used as a research tool to study the function of ion channels and ligands. Nifeviroc binds to the N-terminal domain of the sodium channel, which activates the channel by increasing its permeability to sodium ions. This leads to an increase in membrane potential, depolarization of the cell, and an increase in neuronal excitability. Nifeviroc has been shown to be effective in blocking pain transmission by inhibiting voltage-gated sodium channels (VGSC).

Fórmula: C₃₃H₄₂N₄O₆

Pureza: Min. 95%

Peso molecular: 590.7 g/mol

Ref: 3D-JMB74033

Nifeviroc

CAS: 934740-33-7

Nifeviroc (TD-0232) is an orally active CCR5 antagonist, useful in HIV-1 infection research.

Fórmula: C₃₃H₄₂N₄O₆

Pureza: 98.14%

Cor e Forma: Solid

Peso molecular: 590.7098

Ref: TM-T28171